Imagine if, in a year’s time, 300m doses of a safe and effective Covid-19 vaccine have been manufactured in Donald Trump’s America, Xi Jinping’s China or Boris Johnson’s Britain. Who is going to get them? What are the chances that a nurse in India, or a doctor in Brazil, let alone a bus driver in Nigeria or a diabetic in Tanzania, will be given priority? The answer must be virtually nil.
想象一下，如果在一年內(nèi)，唐納德?特朗普(Donald Trump)領(lǐng)導(dǎo)的美國(guó)、習(xí)近平領(lǐng)導(dǎo)的中國(guó)或鮑里斯?約翰遜(Boris Johnson)領(lǐng)導(dǎo)的英國(guó)生產(chǎn)出了3億劑安全有效的新型冠狀病毒肺炎（COVID-19，即2019冠狀病毒病）疫苗，誰(shuí)會(huì)得到它們？印度的護(hù)士、巴西的醫(yī)生，更不用說(shuō)尼日利亞的公交車司機(jī)或坦桑尼亞的糖尿病患者，這些人能優(yōu)先接種疫苗的可能性有多大？答案一定幾乎為零。
您已閱讀9%（581字），剩余91%（5936字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。